Emcure Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 28, 2025
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has informed the stock exchanges about its 44th Annual General Meeting (AGM) scheduled for Thursday, August 28, 2025, at 11:00 a.m. (IST), to be held via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). Members holding shares as of the cut-off date of August 21, 2025, can attend and vote. Remote e-voting will be open from August 25, 2025 (9:00 a.m.) to August 27, 2025 (5:00 p.m.), facilitated by MUFG Intime India. The filing, made under Regulation 34 of SEBI's LODR Regulations, includes the full Annual Report for FY 2024-25, which highlights revenue from operations of Rs. 78,960 million (up 18.6% YoY) and profit after tax of Rs. 7,075 million (up 34.1% YoY). The company also reported strong international growth, with Canada up 35.7%, RoW up 27.9%, and domestic business up 16.4%.
This is a routine regulatory filing accompanying the AGM notice and annual report. Shareholders should review the annual report for detailed financial performance, strategic direction, and items to be voted on at the AGM. The strong FY25 results and growth trajectory are already known, so no new material catalyst is expected from this filing alone.